IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $464,000 | +88.6% | 23,868 | +61.3% | 0.01% | +66.7% |
Q4 2017 | $246,000 | -16.9% | 14,798 | +1.2% | 0.01% | -60.0% |
Q3 2017 | $296,000 | +26.5% | 14,628 | +0.5% | 0.02% | -6.2% |
Q2 2017 | $234,000 | +129.4% | 14,548 | +78.7% | 0.02% | +128.6% |
Q1 2017 | $102,000 | -2.9% | 8,140 | +1.9% | 0.01% | -30.0% |
Q4 2016 | $105,000 | – | 7,990 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NORTH TIDE CAPITAL, LLC | 3,000,000 | $37,950,000 | 5.83% |
Healthcare Value Capital, LLC | 200,000 | $2,530,000 | 4.33% |
Ratan Capital Management LP | 354,400 | $4,483,000 | 2.15% |
SECTOR GAMMA AS | 534,311 | $6,759,000 | 1.08% |
Sivik Global Healthcare LLC | 168,030 | $2,126,000 | 0.99% |
Schonfeld Strategic Advisors LLC | 547,157 | $6,922,000 | 0.69% |
Iguana Healthcare Management, LLC | 100,000 | $1,265,000 | 0.63% |
Century Capital Management, LLC | 250,716 | $3,172,000 | 0.50% |
Fosun International Ltd | 300,000 | $3,795,000 | 0.47% |
Atika Capital Management LLC | 39,500 | $499,000 | 0.24% |